Pharmaust finds buyer for CBI

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

WA generic medicines company Pharmaust (ASX: PAA) has found a buyer for its share in Commonwealth Biotechnologies Inc (CBI), a US-based life sciences R&D outsourcing specialist.

In a statement, Pharmaust's board said it had decided that ownership of the shares was doing nothing to help the company's bottom line, but had run into difficulties selling the shares.

The shares were unregistered, meaning they could not be sold on the NASDAQ exchange and had to be sold privately.

The company has finally sourced a likely buyer, Hong Kong-based Venturepharm Laboratories.

Pharmaust shareholders will be asked to vote on the deal on July 11.

Related News

'Mini brains' mimic MS myelin damage

The MS organoids give researchers a highly detailed cellular view of myelin destruction...

Fast-aging placentas may contribute to pre-eclampsia

Placentas affected by pre-eclampsia show several signs of accelerated aging, including increased...

BioNTech opens mRNA manufacturing facility at La Trobe

Offering state-subsidised access to researchers and biotech startups, the facility aims to enable...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd